What is Glaukos's acquisitions?

Glaukos (GKOS) reported acquisitions of $3.11M in Q4 2025.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Glaukos GKOS Acquisitions

Acquisitions at other companies

Johnson & JohnsonJNJ

$17.5B—

AbbVieABBV

$0-100%

Opko HealthOPK

$0—

Boston ScientificBSX

$523M+119%

Other financials

Income statement

See full

Revenue$185.6M+49.5%

Gross profit$151.6M+55.9%

Operating income-$17.3M+23.9%

Net income-$18.4M+6.5%

EPS (diluted)-$0.31+8.8%

Balance sheet

See full

Cash & equivalents$114.5M+13.6%

Total debt$105.9M-1.4%

Total equity$682.5M-10.8%

Total assets$920.5M-6.7%

Cash flow

See full

Operating cash flow$14.8M—

CapEx$2.7M+132%

Free cash flow-$16.5M+19.4%

Valuation

See full

Market cap$8.92B+64.5%

Enterprise value$8.91B+64.1%

P/S14.6×+2.0×

Profitability

See full

Gross margin61%-15.4pp

Operating margin-31.6%+22.2pp

Net margin-30.7%+23.3pp

FCF margin-13.2%-3.9pp

Returns & leverage

See full

Return on equity-26%-11,301pp

Debt / equity0.2×0.0×

Current ratio5×-0.5×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Glaukos’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Glaukos's acquisitions?: Glaukos (GKOS) reported acquisitions of $3.11M in Q4 2025.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.